With the changes to the regulation of veterinary medicines in the UK as a result of Brexit, the Veterinary Medicines Directorate has created a helpful information hub pulling together its communications on current and future regulatory changes. Access the Hub here, including useful explainers on “Application and authorisation”, “Manufacturing and distribution”,…

As previously discussed in our article on Brexit-related challenges for the life sciences sector dated 12 February 2021, batch testing was omitted from the Trade and Cooperation Agreement (TCA) signed by the UK and EU on 30 December 2020. Whilst the EU is yet to grant recognition of batch testing,…

In response to the Conservative Party’s manifesto promise, both industry and government have agreed to make production of new drugs to patients as attractive and innovation-embracing as possible. This, coupled with MHRA emerging from under the European Medicines Agency to function as a wholly independent body, presents an ongoing challenge.…